N-Acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo
- 1 October 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 236 (2) , 91-94
- https://doi.org/10.1016/s0304-3940(97)00769-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- NMDA-dependent modulation of CA1 local circuit inhibitionJournal of Neuroscience, 1996
- Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic DegenerationEuropean Journal of Neuroscience, 1995
- The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal deathNeuropharmacology, 1995
- N‐Acetylaspartylglutamate Selectively Inhibits Neuronal Responses to N‐Methyl‐d‐Aspartic Acid In VitroJournal of Neurochemistry, 1994
- N-acetyl-aspartylglutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitroNeuroReport, 1994
- Excitatory amino acid neurotoxicity and neurodegenerative diseaseTrends in Pharmacological Sciences, 1990
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- The Neurobiology of N-AcetylaspartyPublished by Elsevier ,1988
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986